Evidence map›Paper›PMID 41054796›Full record

ArticleThe journal of physical chemistry. B2025

Impact of Bile Acid Amidation on In Silico Farnesoid X Receptor Dynamics.

Riley K Eisert-Sasse, Arumay Biswas, C Denise Okafor

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Riley K Eisert-SasseDepartment of Chemistry, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.ORCID 0000-0002-2801-8857
Arumay BiswasDepartment of Chemistry, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.ORCID 0009-0009-3135-1341
C Denise OkaforDepartment of Chemistry, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.ORCID 0000-0001-7374-1561

Funding

Improving drug design to eliminate side effects: From computational to animal modelsDP2GM149753 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI OKAFOR, C. DENISE · 2022 to 2025
$2.3M
NIGMS NIH HHS DP2 GM149753
6 · The paper itself

Abstract

While the behavior of amidated bile acids has been well studied in vitro, and there is a growing body of in silico research on bile acids, the effects of amidated bile acids on the dynamics and behavior of the farnesoid X receptor (FXR) are yet to be characterized. Although amidated bile acids are larger and more hydrophobic than nonamidated bile acids, their in vitro functions can often be remarkably similar. To investigate the impact of these changes on protein behavior, classical molecular dynamics simulations were performed on the ligand-binding domain of FXR bound to the primary human bile acids and their glycine- and taurine-conjugated amidates. We observe that amino acid conjugation leads to changes in critical local interactions, including salt bridges in the binding pocket and contacts at the FXR aromatic triad. Despite these effects, the global dynamic behavior of the receptor remains surprisingly consistent across all of the ligands studied. The absence of large perturbations in FXR dynamics appears to be consistent with the reports of similar in vitro activity of glyco- and tauroconjugates with primary bile acids. Moreover, these results suggest that global versus local differences in FXR dynamics may correlate differently with experimental measurements.

Indexed as

Bile Acids and SaltsMolecular Dynamics SimulationReceptors, Cytoplasmic and NuclearBinding SitesHumansLigandsReceptor, Farnesoid X-ActivatedBile Acids and SaltsLigandsReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and Nuclear

Identifiers

PMID41054796
PMCPMC12536397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.